Starpharma Holdings Limited has released a press release.
Positive DEP HER2-Lu preclinical data support Phase 1 entry
Earlier from Starpharma
- FDA confirms path to DEP HER2 first-in-human study
- Half Yearly Report and Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report
- AGM Chair address and CEO presentation